Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.
Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
52 | 60 | 59 | 65 | 71 | 11 | 19 | 26 | 45 | 44 | 52 | 59 | 54 | 13 | 14 |
Research, Review articles and Editorials |
14 | 14 | 19 | 41 | 29 | 11 | 15 | 16 | 17 | 34 | 40 | 42 | 38 | 10 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
38 | 46 | 40 | 30 | 42 | 0 | 4 | 10 | 28 | 10 | 12 | 17 | 21 | 3 | 4 |
Conference proceedings |
18 | 8 | 32 | 23 | 0 | 0 | 112 | 104 | 154 | 315 | 180 | 116 | 110 | 122 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
121 | 206 | 193 | 258 | 232 | 212 | 200 | 205 | 224 | 245 | 110 | 61 | 22 | 20 | 0 |
Journal total citations count | 2341 |
Journal impact factor | 2.87 |
Journal 5 years impact factor | 3.73 |
Journal cite score | 4.69 |
Journal h-index | 24 |
Vuppala G, Pulagam U, Anumakonda D. Research & Reviews: Journal of Medical and Health Sciences.
Sharma P, Garg N, Sharma A, Capalash N, Singh R. Nucleases of bacterial pathogens as virulence factors, therapeutic targets and diagnostic markers. International Journal of Medical Microbiology. 2019: 151354.
Hashemzehi R, Doosti A, Kargar M, Jaafarinia M. Gene cloning and evaluation of the Acinetobacter baumannii nlpD gene expression in human dermal fibroblast cells using RT-PCR. KAUMS Journal (FEYZ). 2017;21: 359-366.
Vuppala G, Pulagam U, Anumakonda D. Research & Reviews: Journal of Medical and Health Sciences.
Kuranasree P. A brief study on hemorrhagic septicemia. Res Rev J Vet Sci. 2016;2: 30-37.
Vuppala G, Pulagam U, Anumakonda D. Research & Reviews: Journal of Medical and Health Sciences.
Bruxelle JF, Péchiné S, Collignon A. Immunization Strategies Against Clostridium difficile. InUpdates on Clostridium difficile in Europe 2018.
Péchiné S, Bruxelle JF, Janoir C, Collignon A. Targeting Clostridium difficile surface components to develop immunotherapeutic strategies against Clostridium difficile infection. Frontiers in microbiology. 2018.
Clements JD, Norton EB. The mucosal vaccine adjuvant LT (R192G/L211A) or dmLT. mSphere. 2018;3: e00215-18.
Baliban SM, Curtis B, Amin MN, Levine MM, Pasetti MF, Simon R. Maternal antibodies elicited by immunization with an O-polysaccharide glycoconjugate vaccine protect infant mice against lethal Salmonella Typhimurium infection. Frontiers in immunology. 2019;10: 2124.
Vuppala G, Pulagam U, Anumakonda D. Research & Reviews: Journal of Medical and Health Sciences.
Rossi O, Coward C, Goh YS, Claassens JW, MacLennan CA, Verbeek SJ, et al. The essential role of complement in antibodyâ€mediated resistance to Salmonella. Immunology. 2019;156: 69-73.
Perez-Shibayama C, Gil-Cruz C, Cheng HW, Onder L, Printz A, Mörbe U, Novkovic M, et al. Fibroblastic reticular cells initiate immune responses in visceral adipose tissues and secure peritoneal immunity. Science immunology. 2018;3: eaar4539.
Baliban SM, Curtis B, Toema D, Tennant SM, Levine MM, Pasetti MF, et al. Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS: FliC glycoconjugates in infant and adult mice. PLoS neglected tropical diseases. 2018;12: e0006522.
Vuppala G, Pulagam U, Anumakonda D. Research & Reviews: Journal of Medical and Health Sciences.
Madhusudhan L. Floral Festival: A Culture of Telangana. Arts and Social Sciences Journal. 2016;7: 227-231.
Galal NM, Meshaal S, ElHawary R, Nasr E, Bassiouni L, Ashghar H, Farag NH, Mach O, Burns C, Iber J, Chen Q. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication. BMC research notes. 2018;11: 717.
Macklin G, Liao Y, Takane M, Dooling K, Gilmour S, Mach O, Kew OM, Sutter RW, Diop O, Moeletsi NG, Williams R. Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the World Health Organization registry. Frontiers in immunology. 2017;8: 1103.
Aghamohammadi A, Abolhassani H, Kutukculer N, Wassilak SG, Pallansch MA, Kluglein S, Quinn J, Sutter RW, Wang X, Sanal O, Latysheva T. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication. Frontiers in immunology. 2017;8: 685.
Zencirci SA, MetintaÅŸ S. Developments in malaria vaccines. 2017.